The phase 0 microdosing concept

被引：67

作者：

Garner, RC ^{[1
]}

Lappin, G ^{[1
]}

机构：

[1] Xceleron Ltd, York Bioctr, York YO10 5NY, N Yorkshire, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 61卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.2006.02575.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：367 / 370

页数：4

共 10 条

[1] In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography [J].

Aboagye, EO ;

Price, PM ;

Jones, T .

DRUG DISCOVERY TODAY, 2001, 6 (06) :293-302

[2]

[Anonymous], 2004, INN STAGN CHALL OPP

[3] Positron emission tomography microdosing:: a new concept with application in tracer and early clinical drug development [J].

Bergström, M ;

Grahnén, A ;

Långström, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (5-6) :357-366

[4]

Committee for Medicinal Products for Human Use EMA, 2004, CPMPSWP259902REV1 EM

[5] The price of innovation: new estimates of drug development costs [J].

DiMasi, JA ;

Hansen, RW ;

Grabowski, HG .

JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185

[6] Modern biomedical research: an internally self-consistent universe with little contact with medical reality? [J].

Horrobin, DF .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (02) :151-154

[7] Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry [J].

Lappin, G ;

Garner, RC .

ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2004, 378 (02) :356-364

[8] Big physics, small doses: the use of AMS and PET in human microdosing of development drugs [J].

Lappin, G ;

Garner, RC .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :233-240

[9]

*US DEP HHS FOOD D, 2006, GUID IND EXPL IND ST

[10]

2003, PAREXELS PHARM R D S

← 1 →